# Formal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/formal-meetings-between-the-fda-and-sponsors-or-applicants-of-pdufa-products/3344b1c7-a603-4d25-a0d9-fa9de797e2e7

> FDA guidance document: Formal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products. Issue date: September 22, 2023. Get complete insights and analysis.

---

## Details

- Title: Formal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2023-09-22
- Comment Close Date: 2023-12-21
- Last Changed: 2023-09-22
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2017-D-6530">FDA-2017-D-6530</a>

## Related Documents

- [Labeling for Biosimilar and Interchangeable Biosimilar Products](https://www.globalkeysolutions.net/guidances/guidance-document/labeling-for-biosimilar-and-interchangeable-biosimilar-products/54a5f712-03f5-4993-b0d7-6a1c2f261eff)
- [Risk Management Plans to Mitigate the Potential for Drug Shortages](https://www.globalkeysolutions.net/guidances/guidance-document/risk-management-plans-to-mitigate-the-potential-for-drug-shortages/bd27fc63-0c90-4718-abd5-2b5af99e540e)
- [Fabry Disease: Developing Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/fabry-disease-developing-drugs-for-treatment-guidance-for-industry/37d2e0fe-939f-490c-8fec-d2753a0f2f8c)